Cancer stem cell gene variants and colon cancer outcome

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00004557

Enrollment

1061

Registered

2012-11-21

Start date

2013-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C18

Interventions

Group 1: 1. Patients with stage II and III colon cancer, treated with 5-FU based chemotherapy: Validation of the genetic biomarkers 2. Patients treated with surgery alone: Evaluation of the predictive

Eligibility

Sex/Gender

All

Age

18 Years to 95 Years

Inclusion criteria

Inclusion criteria: Colon cancer in stage II and III after curative surgery

Exclusion criteria

Exclusion criteria: Colon cancer in stage I and IV

Design outcomes

Primary

Measure	Time frame
Prediction of the time to Tumor recurrence based on the genetic biomarkers	—

Secondary

Measure	Time frame
Prediction of overall survival based on the genetic biomarkers	—

Countries

Austria

Contacts

Public ContactArmin Gerger

Klinische Abteilung für Onkologie, Medizinische Universität Graz

armin.gerger@medunigraz.at004331638580625

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026